 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | lanthanum polystyrene sulfonate powder / Liaoning Grand Nuokang Biopharma
Trial completion date, Trial primary completion date: To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder (clinicaltrials.gov) - Jun 7, 2021
P1/2, N=48, Recruiting, Sponsor: Liaoning Grand Nuokang Biopharmaceutical Co., Ltd.
Trial completion date: Apr 2022 --> Dec 2022 | Trial primary completion date: Dec 2021 --> Jun 2022
- || lanthanum polystyrene sulfonate powder / Liaoning Grand Nuokang Biopharma
Enrollment open, Trial initiation date: To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder (clinicaltrials.gov) - Oct 28, 2020
P1/2, N=48, Recruiting, Sponsor: Liaoning Grand Nuokang Biopharmaceutical Co., Ltd.
Trial completion date: Apr 2022 --> Dec 2022 | Trial primary completion date: Dec 2021 --> Jun 2022 Not yet recruiting --> Recruiting | Initiation date: Jul 2020 --> Oct 2020
- | lanthanum polystyrene sulfonate powder / Liaoning Grand Nuokang Biopharma
New P1/2 trial: To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder (clinicaltrials.gov) - Jun 22, 2020
P1/2, N=48, Not yet recruiting, Sponsor: Liaoning Grand Nuokang Biopharmaceutical Co., Ltd.